Introduction. The severity and prevalence of Post-Acute COVID-19 Sequela (PACS) or long-
COVID syndrome (long COVID) should not be a surprise. Long-COVID symptoms may be …

Introduction On March 11, 2020, the World Health Organization sounded the COVID-19
pandemic alarm. While efforts in the first few months focused on reducing the mortality of …

Patients with long COVID suffer from many neurological manifestations that persist for 3
months following infection by SARS-CoV-2. Autonomic dysfunction (AD) or dysautonomia is …

As global numbers of COVID-19 grow, chronic neurological symptoms, including those of
autonomic dysfunction, are being reported with increasing frequency. Mounting evidence …

Abstract Purpose of Review Long-COVID is a novel condition emerging from the COVID-19
pandemic. Long-COVID is characterized by symptoms commonly seen in autonomic …

Introduction Evidence is emerging about an extra-pulmonary involvement of SARS-CoV-2,
including the nervous system. Autonomic dysfunction in patients recovering from acute …

Among the plethora of debilitating neurological disorders of COVID-19 syndrome in
survivors, the scope of SARS-CoV-2-induced dysautonomia (DNS) is yet to be understood …

Background The association between autonomic dysfunction and long‐COVID syndrome is
established. However, the prevalence and patterns of symptoms of dysautonomia in long …

A significant proportion of patients infected from SARS-CoV-2 experience new, recurring, or
ongoing symptoms usually 3 months after infection that may last for weeks or months and …

Although autonomic dysfunction (AD) after the recovery from Coronavirus disease 2019
(COVID-19) has been thoroughly described, few data are available regarding the …